Telemonitoring Alerts and Blood Pressure Control in Rural Hypertension Patients
Keywords:
Telemonitoring, Hypertension, Rural Health, Clinical Alerts, Digital Health IntegrationAbstract
Hypertension remains a leading cause of cardiovascular morbidity and mortality globally, with rural populations facing disproportionate risks due to geographic and socioeconomic barriers to healthcare access. Telemonitoring has emerged as a promising strategy to bridge this gap, yet the mechanisms by which remote data collection translates into tangible clinical outcomes remain insufficiently understood. This implementation study investigates the direct link between telemonitoring alerts and blood pressure control among rural hypertension patients. Over a twelve-month period, we evaluated a digital health intervention deployed in resource-constrained settings, focusing on how automated clinical alerts generated by home blood pressure readings influence provider response times, patient engagement, and ultimate hemodynamic control. The findings indicate that the clinical responsiveness to actionable alerts is a critical determinant of treatment success, significantly outperforming passive data collection models. Furthermore, the integration of telemonitoring systems into rural primary care workflows faces unique infrastructural and behavioral challenges, including alert fatigue and connectivity issues. By elucidating the operational pathways that maximize the efficacy of digital health alerts, this study provides actionable evidence for optimizing telehealth programs. The insights derived from this research are vital for policymakers and healthcare administrators seeking to scale rural telecardiology initiatives and improve chronic disease management in underserved communities.References
1. Tan, M.L.; Zhao, P.; Zhang, L.; Ho, Y.F.; Varma, M.V.S.; Neuhoff, S.; Nolin, T.D.; Galetin, A.; Huang, S.M. Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates. Clin. Pharmacol. Ther. 2019, 105, 719–729.
2. Martischang, R.; Nikolaou, A.; Daali, Y.; Samer, C.F.; Terrier, J. Guidance on Selecting Optimal Steady-State Tacrolimus Concentrations for Continuous IV Perfusion: Insights from Physiologically Based Pharmacokinetic Modeling. Pharmaceuticals 2024, 17, 1047.
3. Singh, D.K.; Ahire, D.; Davydov, D.R.; Prasad, B. Differential Tissue Abundance of Membrane-Bound Drug Metabolizing Enzymes and Transporter Proteins by Global Proteomics. Drug Metab. Dispos. 2024, 52, 1152–1160.
4. Emoto, C.; Hahn, D.; Euteneuer, J.C.; Mizuno, T.; Vinks, A.A.; Fukuda, T. Next Challenge From the Variance in Individual Physiologically-Based Pharmacokinetic Model-Predicted to Observed Morphine Concentration in Critically Ill Neonates. Clin. Pharmacol. Ther. 2020, 107, 319–320.
5. Polasek, T.M. Virtual twin for healthcare management. Front. Digit. Health 2023, 5, 1246659.
6. Brown, B.H.; Barber, D.C.; Seagar, A.D. Applied potential tomography: Possible clinical applications. Clin. Phys. Physiol. Meas. 1985, 6, 109–121.
7. Costa, E.L.V.; Chaves, C.N.; Gomes, S.; Beraldo, M.A.; Volpe, M.S.; Tucci, M.R.; Schettino, I.A.; Bohm, S.H.; Carvalho, C.R.; Tanaka, H.; et al. Real-time detection of pneumothorax using electrical impedance tomography. Crit. Care Med. 2008, 36, 1230–1238.
8. Ke, X.-Y.; Hou, W.; Huang, Q.; Hou, X.; Bao, X.Y.; Kong, W.X.; Li, C.X.; Qiu, Y.Q.; Hu, S.Y.; Dong, L.H. Advances in electrical impedance tomography-based brain imaging. Mil. Med. Res. 2022, 9, 13.
9. Zhang, Y.; Ye, J.; Jiao, Y.; Zhang, W.; Zhang, T.; Tian, X.; Shi, X.; Fu, F.; Wang, L.; Xu, C. A pilot study of contrast-enhanced electrical impedance tomography for real-time imaging of cerebral perfusion. Front. Neurosci. 2022, 16, 1027948. [ Central]
10. Iwashita, Y.; Takeda, S.; Kawashima, S.; Koshi, T.; Nomura, K.I.; Sato, S.; Sato, R.; Yamada, N.; Nebuya, S. A Clinical Case of Three-Dimensional Electrical Impedance Tomography (3D-EIT) Measurements. Cureus 2024, 16, e73291. [ Central]
11. Jiang, Y.D.; Soleimani, M. Capacitively Coupled Electrical Impedance Tomography for Brain Imaging. IEEE Trans. Med. Imaging 2019, 38, 2104–2113.
12. Rostami-Hodjegan, A.; Tucker, G.T. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat. Rev. Drug Discov. 2007, 6, 140–148.
13. Drummond, D.; Gonsard, A. Definitions and Characteristics of Patient Digital Twins Being Developed for Clinical Use: Scoping Review. J. Med. Internet Res. 2024, 26, e58504.
14. Dunson, D.B. Commentary: Practical Advantages of Bayesian Analysis of Epidemiologic Data. Am. J. Epidemiol. 2001, 153, 1222–1226.
15. Silva, J.Q.D.; Moraes, N.V.; Estrela, R.; Coelho, D., Jr.; Feriani, D.; Migotto, K.; Caruso, P.; Silva, I.; Oliveira, D.A.; Telles, J.P.; et al. Amikacin Dosing Adjustment in Critically Ill Oncologic Patients: A Study with Real-World Patients, PBPK Analysis, and Digital Twins. Pharmaceutics 2025, 17, 297.
16. Lau, J.; Schmid, C.H.; Chalmers, T.C. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J. Clin. Epidemiol. 1995, 48, 45–57; discussion 59–60.
17. Roy, N.; Downes, M.H.; Ibelli, T.; Amakiri, U.O.; Li, T.; Tebha, S.S.; Balija, T.M.; Schnur, J.B.; Montgomery, G.H.; Henderson, P.W. The Psychological Impacts of Post-Mastectomy Breast Reconstruction: A Systematic Review. Ann. Breast Surg. Open Access J. Bridge Breast Surg. World 2024, 8, 19.
18. Mostafa, S.; Polasek, T.M.; Bousman, C.; Rostami-Hodjegan, A.; Sheffield, L.J.; Everall, I.; Pantelis, C.; Kirkpatrick, C.M.J. Delineating gene-environment effects using virtual twins of patients treated with clozapine. CPT Pharmacomet. Syst. Pharmacol. 2023, 12, 168–179.
19. Lee, J.J.; Chu, C.T. Bayesian clinical trials in action. Stat. Med. 2012, 31, 2955–2972.
20. Krauss, M.; Tappe, K.; Schuppert, A.; Kuepfer, L.; Goerlitz, L. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations. PLoS ONE 2015, 10, e0139423.
21. Pourian, M.; Mostafazadeh, D.B.; Soltani, A. Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms. J. Diabetes Metab. Disord. 2016, 15, 11.
22. Dzobo, K.; Wilgus, T.A.; Mora, V.Z.; Zoncsich, A.; de Mezerville, R.; Khumalo, N.; Bayat, A. Biomimetic Optimization of Silicone Breast Implant Integration: Insights into Wound Healing and the Foreign Body Response. Front. Bioeng. Biotechnol. 2025, 13, 1668930.
23. Delpierre, C.; Lefèvre, T. Precision and personalized medicine: What their current definition says and silences about the model of health they promote. Implication for the development of personalized health. Front. Sociol. 2023, 8, 1112159.
24. Mansoor, A.; Mahabadi, N. Volume of Distribution. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2025.
25. Upton, R.N.; Foster, D.J.R.; Abuhelwa, A.Y. An introduction to physiologically-based pharmacokinetic models. Pediatr. Anesth. 2016, 26, 1036–1046.
26. Electrospun Poly(ε-Caprolactone) Fiber Scaffolds Functionalized by the Covalent Grafting of a Bioactive Polymer: Surface Characterization and Influence on in Vitro Biological Response | ACS Omega. Available online: https://pubs.acs.org/doi/10.1021/acsomega.9b01647 (accessed on 7 March 2026).
27. Polasek, T.M.; Rostami-Hodjegan, A. Virtual Twins: Understanding the Data Required for Model-Informed Precision Dosing. Clin. Pharmacol. Ther. 2020, 107, 742–745.
28. Darwich, A.S.; Ogungbenro, K.; Vinks, A.A.; Powell, J.R.; Reny, J.L.; Marsousi, N.; Daali, Y.; Fairman, D.; Cook, J.; Lesko, L.J.; et al. Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future. Clin. Pharmacol. Ther. 2017, 101, 646–656.
29. Necchi, S.; Molina, D.; Turri, S.; Rossetto, F.; Rietjens, M.; Pennati, G. Failure of Silicone Gel Breast Implants: Is the Mechanical Weakening Due to Shell Swelling a Significant Cause of Prostheses Rupture? J. Mech. Behav. Biomed. Mater. 2011, 4, 2002–2008.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), unless otherwise stated.